Signal transducing adaptor protein-2 (STAP-2) is a recently identified adaptor protein as a c-Fms/M-CSF receptor-interacting protein and constitutively expressed in macrophages. Our previous studies also revealed that STAP-2 binds to MyD88 and IKK-a/b, and modulates NF-kB signaling in macrophages. In the present study, we 
Introduction
Colony-stimulating factors (CSFs) are involved in normal progress of hematopoietic progenitor cells into terminal differentiated state [1] . Macrophage-CSF (M-CSF/CSF-1) interacts with a single class of high-affinity receptors and controls the development of macrophages from myeloid progenitors [2, 3, 4] . The receptor for M-CSF is identical to the c-fms protooncogene product (c-Fms) and is endowed with intrinsic tyrosine kinase activity that is transmitted through M-CSF binding. M-CSF induces dimerization of its receptor, leading to autophosphorylation of a number of tyrosine residues through the cytoplasmic domain of the receptor that serve as binding sites for the Src homology 2 (SH2) domain-containing proteins, such as Src-family kinases, Grb2 and phosphatidylinositol 3-kinase (PI3K). These then facilitate activation of signal transduction pathways that control macrophage proliferation, differentiation and motility. For example, activation of ERK signaling promotes macrophage proliferation [5, 6] , while activation of PI3K enhances macrophage survival and migration via Akt [7, 8, 9] . In addition, two point mutations at 301 and 969 in the human c-fms gene have been known to confer constitutive tyrosine kinase activity on the receptor and activate its transforming potential [10] .
We have cloned a novel adaptor molecule, signal transducing adaptor protein-2 (STAP-2) [11] whose human homolog is identical to a recently cloned adaptor molecule, BKS, a substrate of Brk (breast tumor kinase) [12] . STAP-2 contains an N-terminal Pleckstrin homology (PH) and a region distantly related to the SH2 domain as well as the proline-rich, tyrosine phosphorylation motifs and a YXXQ motif in its C-terminal region. STAP-2 is expressed in a variety of tissues and cells such as lymphocytes and macrophages as well as hepatocytes, and its abundant expression pattern has suggested wide range of functions in vivo. Indeed, we have reported that STAP-2 can modulate STAT3 and STAT5 transcriptional activity as well as FceRI-and toll like receptormediated signals [11, 13, 14, 15] . Importantly, STAP-2 is constitutively expressed in macrophages and binds to MyD88 and IKK-a/b [15] . Because our identification of STAP-2 was originally performed based on the capacity to recognize c-Fms, we here examined functional roles of STAP-2 in c-Fms-mediated signals.
In the present study, overexpression of STAP-2 in a macrophage cell line, Raw 264.7 resulted in impaired M-CSF-induced tyrosine phosphorylation of c-Fms and downstream signaling proteins including PI3K/Akt and Ras/ERK. Furthermore, we showed that c-Fms directly interacts with the PH domain of STAP-2. Finally, ectopically expressed STAP-2 resulted in impaired M-CSF-induced migration and wound-healing process. These results indicate that STAP-2 is a negative modulator in cFms-mediated signaling required for macrophage motility.
Materials and Methods

Reagents and antibodies
Recombinant human M-CSF was a kind gift from Morinaga Milk Industry Co., Ltd (Tokyo, Japan). Expression vectors, c-Fms, epitope-tagged STAP-2 and its YF (substitution of Tyr to Phe) mutants were described previously [11, 13, 16] . Antibody against c-Fms, ERK1, and GST antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Anti-Myc, anti-phosphotyrosine monoclonal (PY20), and anti-Actin antibodies were purchased from Sigma (St Louis, MO, USA).
Antibodies against Akt, phospho-Akt, phospho-ERK, and phospho-c-Fms were purchased from Cell Signaling Technology (Beverly, MA, USA). Anti-phosphoSTAP-2 Tyr250 (anti-pSTASP-2 Tyr250) and anti-mouse STAP-2 antibodies were prepared as described previously [16] .
Cell culture, transfection and cell growth assays
Murine macrophage cell line, Raw264.7, was cultured in Dulbecco's modified Eagle's 7 medium (DMEM) supplemented with 10% fetal bovine serum (FBS). Stable Raw264.7 cell transformants expressing empty vector, STAP-2 WT or STAP-2 mutants (Raw/STAP-2DPH, Raw/STAP-2DSH2 or Raw/STAP-2DC) were prepared as described previously [15] . Human embryonic kidney carcinoma cell line, 293T, was maintained in DMEM containing 10% FCS and transfected by the standard calcium precipitation protocol [13] .
Cell migration assay
In vitro macrophage migration assay was conducted as previously described [17] .
Briefly, the transwell filters (8 mM pore filter; BD Falcon, Franklin lakes, NJ, USA) were placed in the lower chamber containing 500 ml complete medium with or without M-CSF (100 ng/ml). Raw 264.7 cells (2.5x10 5 ) were resuspended in 100 ml DMEM and allowed to migrate toward the underside of the top chamber. After 24 hrs of incubation at 37°C, the numbers of migrated cells of the lower chamber were counted with a phase contrast microscope.
Wound-healing assay 8
Wound-healing assay was performed as described previously [17] . The assay was conducted in 6-well tissue-culture plates. Raw 264.7 cells were cultured as a confluent monolayer, an artificial wound was created by scraping with a pipette tip, and cells migrating into open space were monitored microscopically. Photographs were taken immediately and at various intervals.
Immunoprecipitation and immunoblotting
The immunoprecipitation and Western blotting assays were performed as described previously [13] . Cells were harvested and lysed in lysis buffer (50 mM Tris-HCl, pH 7.4, 0.15 M NaCl, containing 1% NP-40, 1 mM sodium orthovanadate and 1 mM phenylmethylsulfonyl fluoride). An aliquot of total cell lysates were resolved on SDS-PAGE and transferred to PVDF transfer membrane (PerkinElmer; Boston, MA, USA).
The filters were then immunoblotted with the respective antibody.
Results and Discussion
Molecular interactions between STAP-2 and c-Fms
We originally identified STAP-2 as a c-Fms-interacting protein with a yeast twohybrid system [11] . (Fig. 1B) . Therefore, association of STAP-2 with c-Fms was always observed and ligand-activation of c-Fms was not required.
In order to identify which domain(s) of STAP-2 mediated its interaction with c-Fms, various mutants of STAP-2 were created (Fig. 1C) . The ability of c-Fms to bind to the various GST-fused STAP-2 mutants was tested by co-expressing the proteins in 293T cells and then immunoprecipitating using anti-c-Fms antibody. Western blotting with an anti-GST antibody revealed that the immunoprecipitates with anti-c-Fms antibody predominantly contained the PH domain, but not the C-terminal domain of STAP-2, while the SH2 domain of STAP-2 weakly interacted with c-Fms (Fig. 1D) . Therefore, [15] . In contrast, association of STAP-2 with phospholipase C-g is dependent on FceR activation [14] .
M-CSF-induced phosphorylation on tyrosine-250 of STAP-2 by c-Fms
The physical interactions between STAP-2 and c-Fms clued us to investigate tyrosine-phosphorylation of STAP-2 by c-Fms. As shown in Fig Previous studies have demonstrated that STAP-2 is tyrosine-phosphorylated by several protein tyrosine kinases, including Brk, v-src, Jak2, Syk and EGFR [11, 12, 16] .
Similarly, tyrosine-phosphorylation of STAP-2 was induced by c-Fms after M-CSFstimulation. Up to date, we have shown that leukemia inhibitory factor-induced phosphorylation of STAP-2 on Tyr-250 is involved in its STAT3-enhancing activity [16] .
Therefore, c-Fms-induced tyrosine-phosphorylation of STAP-2 may play a role in activation of the downstream signaling molecules as the case of STAT3.
STAP-2 suppresses M-CSF-induced tyrosine-phosphorylation of c-Fms and Akt activation in Raw 264.7 cells
To assess the functional relevance between STAP-2 and c-Fms-mediated signaling, we established stable transformants expressing STAP-2 in Raw264.7 cells [15] , and used them to evaluate the effect of STAP-2 on the M-CSF-induced signaling. STAP-2 expression of each Raw264.7 clone was confirmed with western blot (data not shown).
Ectopic expression of STAP-2 did not influence on cell growth or cell viability in M-CSF induces recruitment of the p85 subunit of PI3K to c-Fms and Gab2, resulting in rapid activation of the PI3K/Akt and Ras/ERK signaling pathways [5] [6] [7] [8] [9] . Previous studies using pharmacologic inhibitors of PI3K, such as LY294002 [9] as well as injection of antibodies to inhibit the function of the catalytic subunits of PI3K [18] , have suggested a role of the PI3K pathway in macrophage migration. Thus, STAP-2 may regulate M-CSF-induced macrophage migration via the suppression of the PI3K pathway.
STAP-2 suppresses M-CSF-induced macrophage migration in Raw 264.7 cells
Because STAP-2 suppressed M-CSF-induced PI3K/Akt activation, we examined the effect of STAP-2 on migration of Raw 264.7 transfectants with an in vitro migration assay. As shown in Fig. 4A , ectopic expression of STAP-2 results in a significant reduction in directed migration of Raw264.7 cells in response to M-CSF. Macrophages are well known to play a significant role in wound-healing [19] . To assess the functional domains of STAP-2 on M-CSF-induced cell migration, we used stable transformants expressing STAP-2 deletion mutants (Fig. 4B) PI3K p85a has been demonstrated to be crucial for migration in a wound-healing assay compared with wild-type controls [20] . Interestingly, as shown in Fig. 4D, ectopic expression of STAP-2 in Raw 264.7 cells also resulted in reduced migration in an in vitro wound-healing assay. Therefore, STAP-2 plays an important role in the regulation of macrophage migration.
Concluding remarks
Our most important finding is that STAP-2 directly binds to c-Fms and suppresses To maintain macrophage homeostasis, the c-Fms-mediated signaling pathway must be tightly regulated. SOCS-1 and Dok-2 were demonstrated to play roles in the negative regulation of c-Fms signaling [21, 22] . SOCS-1 partially suppresses M-CSF signaling by competing with Grb2, phospholipase C-g 2 or PI3K for binding to Tyr-697 and/or Tyr-721 in the activated c-Fms [22] . Dok-2 regulates c-Fms signaling through inhibition of the phosphorylation of Shc by Src-family kinases, which resulted in impaired inducible gene expression [21] . Another key protein involved in the negative regulation of signaling by c-Fms is c-Cbl, an E3-ubiquitin ligase [23] . c-Cbl terminates c-Fms signaling by binding to the phosphorylated Tyr-973 in the C-terminus of the activated receptor and recruiting E2-ubiquitin ligases to the receptor [24, 25] . Subsequent polyubiquitination of c-Fms by the E2-ubiquitin ligases targets it for internalization and degradation [23] . Importantly, there might be the possibility that STAP-2 also In the present paper, we have described evidence that STAP-2 can directly interact with c-Fms and regulates c-Fms-mediated signaling pathways, especially cell migration.
Further detailed studies are necessary to elucidate the molecular mechanisms of 
